Literature DB >> 19681761

Liposomes as an ocular delivery system of fluconazole: in-vitro studies.

Fawzia S Habib1, Ehub A Fouad, Mohamed S Abdel-Rhaman, Dina Fathalla.   

Abstract

PURPOSE: To study the clinical effect of topical controlled-release ophthalmic fluconazole liposomal formulation and to compare its effect with fluconazole solution in a reproducible model of Candida keratitis in rabbits.
METHODS: Forty adult rabbits were included in this study. Right eyes were inoculated with freshly prepared Caindida albicans strain no. 4925 and showed signs of infected keratitis. The rabbits were divided randomly into two groups: in the first group (18 rabbits) the right eyes received fluconazole solution, while in the second group (22 rabbits) the right eyes received fluconazole-loaded liposomes. The rabbits' eyes were examined daily over a 21-day period and results were recorded.
RESULTS: Rabbits infected with C. albicans responded better and showed more improvement in terms of size of ulcer and hypopyon using fluconazole-loaded liposomal formulae than using fluconazole solution. In the first group (solution), nine rabbits' cornea showed complete healing (50%) at the end of third week while in group 2 (liposome), 19 rabbits' cornea showed complete healing (86.4%) at equal duration. These results were statistically significant.
CONCLUSION: Therapy with topical liposomal fluconazole (2 mg/ml) was successful in eliminating experimental C. albicans infection of the rabbit cornea and was superior to fluconazole solution.
© 2009 The Authors. Journal compilation © 2009 Acta Ophthalmol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19681761     DOI: 10.1111/j.1755-3768.2009.01584.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  17 in total

Review 1.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.

Authors:  Linda Gyanfosu; George Asumeng Koffuor; Samuel Kyei; Ben Ababio-Danso; Kwabena Peprah-Donkor; Wilson Bright Nyansah; Frederick Asare
Journal:  Int Ophthalmol       Date:  2017-09-12       Impact factor: 2.031

3.  Influence of permeant lipophilicity on permeation across human sclera.

Authors:  He Wen; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2010-08-24       Impact factor: 4.200

4.  Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis.

Authors:  André Ferraz Goiana Leal; Melyna Chaves Leite; Caroline Sanuzi Quirino Medeiros; Isabella Macário Ferro Cavalcanti; Almir Gonçalves Wanderley; Nereide Stela Santos Magalhães; Rejane Pereira Neves
Journal:  Mycopathologia       Date:  2014-11-28       Impact factor: 2.574

5.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

Review 6.  Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.

Authors:  Joanne D Du; Wye-Khay Fong; Suzanne Caliph; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

7.  Recent applications of liposomes in ophthalmic drug delivery.

Authors:  Gyan P Mishra; Mahuya Bagui; Viral Tamboli; Ashim K Mitra
Journal:  J Drug Deliv       Date:  2011-03-01

Review 8.  Nanomedicine approaches for corneal diseases.

Authors:  Shyam S Chaurasia; Rayne R Lim; Rajamani Lakshminarayanan; Rajiv R Mohan
Journal:  J Funct Biomater       Date:  2015-04-30

Review 9.  Relevance of Lipid-Based Products in the Management of Dry Eye Disease.

Authors:  Jean-Sébastien Garrigue; Mourad Amrane; Marie-Odile Faure; Juha M Holopainen; Louis Tong
Journal:  J Ocul Pharmacol Ther       Date:  2017-09-28       Impact factor: 2.671

10.  Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid).

Authors:  Nicolás Gómez-Sequeda; Rodrigo Torres; Claudia Ortiz
Journal:  Nanotechnol Sci Appl       Date:  2017-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.